WO2000071169A3 - Magnetic resonance tracking of magnetically labeled cells - Google Patents
Magnetic resonance tracking of magnetically labeled cells Download PDFInfo
- Publication number
- WO2000071169A3 WO2000071169A3 PCT/US2000/013826 US0013826W WO0071169A3 WO 2000071169 A3 WO2000071169 A3 WO 2000071169A3 US 0013826 W US0013826 W US 0013826W WO 0071169 A3 WO0071169 A3 WO 0071169A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- magnetic resonance
- sensitive
- mri
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1896—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU51463/00A AU5146300A (en) | 1999-05-21 | 2000-05-19 | Magnetic resonance tracking of magnetically labeled cells |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13542899P | 1999-05-21 | 1999-05-21 | |
US60/135,428 | 1999-05-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000071169A2 WO2000071169A2 (en) | 2000-11-30 |
WO2000071169A3 true WO2000071169A3 (en) | 2001-08-02 |
Family
ID=22468067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/013826 WO2000071169A2 (en) | 1999-05-21 | 2000-05-19 | Magnetic resonance tracking of magnetically labeled cells |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5146300A (en) |
WO (1) | WO2000071169A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9265577B2 (en) | 2007-05-18 | 2016-02-23 | The Johns Hopkins University | Methods and systems for providing planning and dispensation of research and/or treatment for brain disease |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6713173B2 (en) | 1996-11-16 | 2004-03-30 | Nanomagnetics Limited | Magnetizable device |
GB2319253A (en) | 1996-11-16 | 1998-05-20 | Eric Leigh Mayes | Composition, for use in a device, comprising a magnetic layer of domain-separated magnetic particles |
US6986942B1 (en) | 1996-11-16 | 2006-01-17 | Nanomagnetics Limited | Microwave absorbing structure |
US6815063B1 (en) | 1996-11-16 | 2004-11-09 | Nanomagnetics, Ltd. | Magnetic fluid |
EP1376443A1 (en) * | 2002-06-19 | 2004-01-02 | BrainLAB AG | Method and device for determining the migration ways of cells |
US8249813B2 (en) * | 2003-05-22 | 2012-08-21 | Brainlab Ag | System and process for metabolic guidance of introduced cellular material |
DE602004030579D1 (en) * | 2003-06-30 | 2011-01-27 | Eisai R&D Man Co Ltd | MAGNETIC CELL AND METHOD FOR USE THEREOF |
US7848543B2 (en) | 2004-02-05 | 2010-12-07 | Brainlab Ag | Method and system for prediction and management of material and information transport in an organism |
JPWO2005095621A1 (en) * | 2004-03-31 | 2008-02-21 | ジェノミディア株式会社 | Gene transfer regulation method and system using artificial magnetic material |
DE102004052533A1 (en) † | 2004-10-15 | 2006-05-04 | Mykhaylyk, Olga, Dr. | Particles for use in diagnosis and therapy, especially for binding therapeutic agent for treating e.g. tumors and bacterial, rheumatic, neurologic and thrombotic diseases, have nanocrystalline magnetic core and envelope enclosing core |
US8580230B2 (en) | 2009-02-23 | 2013-11-12 | Kent State University | Materials and methods for MRI contrast agents and drug delivery |
DE102009060317B4 (en) | 2009-12-23 | 2013-04-04 | Siemens Aktiengesellschaft | A contrast agent for use in an imaging method for diagnosing a metastatic tumor disease and a method for imaging a metastatic tumor tissue |
US20120052014A1 (en) * | 2010-05-11 | 2012-03-01 | Sufi Oasim Raja | Ferritin biosensor and methods of using the same |
CN113648426A (en) * | 2021-08-18 | 2021-11-16 | 浙江大学 | Construction method and application of magnetic nanoparticles capable of being connected in two directions |
-
2000
- 2000-05-19 WO PCT/US2000/013826 patent/WO2000071169A2/en active Application Filing
- 2000-05-19 AU AU51463/00A patent/AU5146300A/en not_active Abandoned
Non-Patent Citations (6)
Title |
---|
BULTE J W M ET AL: "DEXTRAN-MAGNETITE PARTICLES: CONTRAST-ENHANCED MRI OF BLOOD-BRAIN BARRIER DISRUPTION IN A RAT MODEL*", MAGNETIC RESONANCE IN MEDICINE,US,ACADEMIC PRESS, DULUTH, MN, vol. 23, no. 2, 1 February 1992 (1992-02-01), pages 215 - 223, XP000261759, ISSN: 0740-3194 * |
BULTE J W M ET AL: "Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent", JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS,NL,ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, vol. 194, no. 1-3, April 1999 (1999-04-01), pages 204 - 209, XP004166667, ISSN: 0304-8853 * |
BULTE J W M ET AL: "Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran - magnetite particles", MAGNETIC RESONANCE IN MEDICINE,US,ACADEMIC PRESS, DULUTH, MN, vol. 25, no. 1, 1992, pages 148 - 157, XP002112218, ISSN: 0740-3194 * |
BULTE J.W.M. ET AL: "Short-vs. long-circulating magnetoliposomes as bone marrow-seeking MR contrast agents", J. MAGNETIC RESONANCE IMAGING, vol. 9, February 1999 (1999-02-01), pages 329 - 335, XP000986439 * |
BULTE J.W.M. ET AL: "Tagging of T cells with superparamagnetic iron oxide: Uptake kinetics and relaxometry", ACAD RADIOL., vol. 3, 3 August 1996 (1996-08-03), pages s301 - s303, XP000986426 * |
BULTE, J. W. M. ET AL: "Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination", PNAS, vol. 96, no. 26, 21 December 1999 (1999-12-21), pages 15256 - 15261, XP000982063 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9265577B2 (en) | 2007-05-18 | 2016-02-23 | The Johns Hopkins University | Methods and systems for providing planning and dispensation of research and/or treatment for brain disease |
Also Published As
Publication number | Publication date |
---|---|
WO2000071169A2 (en) | 2000-11-30 |
AU5146300A (en) | 2000-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000071169A3 (en) | Magnetic resonance tracking of magnetically labeled cells | |
Li et al. | A bioinspired nanoprobe with multilevel responsive T1‐weighted MR signal‐amplification illuminates ultrasmall metastases | |
Hawrylak et al. | Nuclear magnetic resonance (NMR) imaging of iron oxide-labeled neural transplants | |
Hilger et al. | Towards breast cancer treatment by magnetic heating | |
Artemov et al. | MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles | |
Groman et al. | Ultrasmall mixed ferrite colloids as multidimensional magnetic resonance imaging, cell labeling, and cell sorting agents | |
EP0330801A1 (en) | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease | |
Tachezy et al. | Tritrichomonas foetus: iron acquisition from lactoferrin and transferrin | |
Chertok et al. | Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers | |
AU8204787A (en) | Detection of necrotic malignant tissue and associated therapy | |
IS2059B (en) | Biochemically activated contrast media for imaging | |
ES2130406T5 (en) | COMPOSITE MATERIAL OF SMALL DIAMETER COMPOSITE OF CARBOXIPOLISACARIDO SOLUBLE IN WATER AND MAGNETIC IRON OXIDE. | |
ATE99544T1 (en) | LIPOSOMAL RADIOLOGICAL CONTRAST AGENT. | |
Gao et al. | Magnetic nanoparticles for biomedical applications: From diagnosis to treatment to regeneration | |
Ramchand et al. | Application of magnetic fluids in medicine and biotechnology | |
Trahms | Biomedical applications of magnetic nanoparticles | |
CA2416526A1 (en) | Extended organic cobalt and nickel magnetic complexes | |
Meng et al. | External magnetic field promotes homing of magnetized stem cells following subcutaneous injection | |
Nair et al. | Monovalent and bivalent fibrin‐specific MRI contrast agents for detection of thrombus | |
TAUBER et al. | The interaction of the high‐density lipoprotein with cultured cells of bovine vascular endothelium | |
CN101636108B (en) | Imaging of activated vascular endothelium using immunomagnetic MRI contrast agents | |
Ramanujan | Magnetic particles for biomedical applications | |
Yan et al. | Development of Y-shaped peptide for constructing nanoparticle systems targeting tumor-associated macrophages in vitro and in vivo | |
Autenshlyus et al. | Magnetic-sensitive dextran-ferrite immunosorbents (for diagnostic and therapy) | |
Li et al. | Enzyme‐Triggered Transforming of Assembly Peptide‐Modified Magnetic Resonance‐Tuned Probe for Highly Sensitive Imaging of Bacterial Infection In Vivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09979464 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |